VTT and Dyadic International presenting excellent results reached in development of a new fungal production platform C1 for vaccines and therapeutic proteins
Credit: Photo: Anne Huuskonen VTT and Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), today announced that VTT scientists will present the excellent results in their collaboration...











